SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy is experiencing a period of extreme volatility and intense retail attention following a recent rally, with the community actively debating whether the move is driven by genuine industrial demand for AI data-center power solutions or if it represents another cycle of speculative pump-and-dump behavior. Investors are closely monitoring management's ability to convert pipeline opportunities into commercial orders, while short sellers and long-term shareholders remain locked in a heated standoff over the stock's valuation and the risk of further dilution.

Penguin Solutions, Inc. engages in designing, building, and managing enterprise solutions. It operates through the following segments: Advanced Computing, Integrated Memory, and Optimized LED. The Advanced Computing segment offers platform solutions and services for artificial intelligence, high-performance computing, machine learning, advanced modeling, and the internet of things. The Integrated Memory refers to integrated memory solutions through the design and development. The Optimized LED segment comprises a broad portfolio of application-optimized LEDs. The company was founded in 1988 and is headquartered in Fremont, CA.

Penguin Solutions Inc.

Penguin Solutions ($PENG) is rallying following a strong earnings report that featured a revenue and EPS beat alongside raised fiscal guidance, fueling optimism around its specialized role in the AI infrastructure supply chain. The community is actively debating the stock's potential for further gains as a long-term AI partner, while some traders closely monitor high short interest and aggressive options positioning as key drivers for potential volatility.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending as investors aggressively accumulate the stock ahead of pivotal Phase 3 maintenance data expected in the third quarter, driving optimism for its GLP-1/GIP weight-loss franchise. Community sentiment is dominated by speculation of a potential buyout or strategic partnership, with many traders framing the current momentum as a long-awaited breakout fueled by sector rotation and trapped short positions.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is facing heightened scrutiny after Wolfspeed filed a patent infringement lawsuit targeting core GaN and SiC product lines, fueling community concerns about a potential long-term legal overhang. Investors are actively debating whether this litigation risk and recent volatility represent a buying opportunity for long-term AI infrastructure exposure or if the stock remains overvalued and vulnerable to further downside.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is gaining significant momentum as investors anticipate the final Phase 3 durability data for its COMP360 treatment, which is critical for an upcoming FDA NDA submission. The community is actively debating the stock's potential for a major re-rating, fueled by recent board appointments, executive-level optimism about commercialization, and the broader institutional rotation into biotech stocks with significant clinical catalysts.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals is seeing significant market interest as it winds down internal R&D in favor of external partnerships, sparking widespread community speculation regarding a potential buyout. Investors are closely monitoring its commercial success and high short interest, interpreting these strategic shifts as a signal that the company is cleaning up its balance sheet to become a more attractive acquisition target for major pharmaceutical players.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is currently the focus of heavy market discussion after announcing a 20-year, 19 billion dollar lease agreement with AI leader Anthropic for its Kentucky data center campus. While the community is debating whether the stock's muted price reaction is due to market-wide volatility, short-selling pressure, or a 'sell-the-news' response, many investors remain bullish on the long-term potential of this transition from bitcoin mining to AI infrastructure.

Securitize Corp. develops a tokenization platform for securities. The private company is based in FL. Carlos Domingo has been the CEO of the American company since 2017.

Securitize Corp.

Securitize Corp. is seeing intense volatility following its recent de-SPAC and the unique integration of on-chain tokenized shares, sparking heavy debate between investors focusing on its long-term potential as a tokenization leader and those concerned about arbitrage-driven selling pressure. Community members are actively analyzing the stock's price behavior against its partnership landscape while navigating the uncertainty typical of new market listings.

American Airlines Group, Inc. is a holding company, which engages in the operation of a network carrier through its principal wholly owned mainline operating subsidiary, American. The firm offers air transportation for passengers and cargo. It operates through the following geographical segments: Domestic, Latin America, Atlantic, and Pacific. The company was founded on December 9, 2013, and is headquartered in Fort Worth, TX.

American Airlines Group Inc

American Airlines is seeing increased volatility as investors react to fluctuating Middle East tensions and concerns over jet fuel costs, while trading activity is heavily influenced by news of new in-flight connectivity partnerships. Community discussion remains polarized, with many traders closely monitoring energy prices and geopolitical news for potential short-term breakouts or pullbacks.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending as investors digest the commercial launch of NEREUS for motion sickness while debating the company's potential as a buyout target for major pharmaceutical players. The community is actively discussing the firm's strategic focus on GLP-1 adjunct treatments and pipeline developments, even as participants express frustration over persistent price volatility and the company's aggressive regulatory strategy.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Mangoceuticals Stock Doubles After Texas Lawsuit

Mangoceuticals stock jumps despite no fresh news, as lawsuit dispute, TRT sales surge, and platform shift shape investor sentiment.read more...

Regulatory Wins, Capital Flows, and Global Expansion Drive Market Momentum

A wave of regulatory clarity, strategic financing, and global expansion is reshaping pockets of the market, with companies across biotech, mobility, and emerging healthcare infrastructure positioning for outsized growth. $MGRX, $TOVX, $ZYBT, $FFAI, $TGNT

Penny Stocks To Follow Now - February 21st

Rackspace Technology, Cardio Diagnostics, Mana Capital Acquisition, Mangoceuticals, and BigBear.ai are the five Penny stocks to watch today, according to MarketBeat's stock screener tool. Penny...

Penny Stocks To Watch Today - February 20th

Rackspace Technology, Cardio Diagnostics, and Mangoceuticals are the three Penny stocks to watch today, according to MarketBeat's stock screener tool. Penny stocks are very low-priced shares...

Mangoceuticals Stock Skyrockets 50% Friday: What's Driving The Rally?

Shares of Mangoceuticals are trading sharply higher Friday afternoon after the company reported momentum for its $99-per-month TRT program.read more...

Mangoceuticals Announces Solana-Focused $100M Digital Asset Treasury, Sees ‘Compelling, Non-Dilutive Returns’

Cryptocurrency

Mangoceuticals had also recently filed a trademark application for “MULTI-DAT” with the United States Patent and Trademark Office in a bid to expand into the digital asset space. 

Insider Selling: Mangoceuticals (NASDAQ:MGRX) CFO Sells 10,000 Shares of Stock

Mangoceuticals, Inc. (NASDAQ:MGRX - Get Free Report) CFO Eugene Johnston sold 10,000 shares of Mangoceuticals stock in a transaction that occurred on Friday, December 5th. The shares were sold at an...

Insider Selling: Mangoceuticals (NASDAQ:MGRX) Director Sells 125,000 Shares of Stock

Mangoceuticals, Inc. (NASDAQ:MGRX - Get Free Report) Director Alex Hamilton sold 125,000 shares of the stock in a transaction on Wednesday, November 19th. The shares were sold at an average price of...

Why Did Mangoceuticals Shares Rise Today?

Equity

 The company has launched two programs, MangoRx Direct and PeachesRx Direct, to provide access to Lilly’s Zepbound and Novo’s Wegovy medicines.


Mangoceuticals, Inc. engages in developing, marketing, and selling men's wellness products and services via a telemedicine platform. The company was founded on October 7, 2021 and is headquartered in Dallas, TX.

Mangoceuticals Inc

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$0.3728
Prev Close	$0.4391
Open	$0.44
Dividend Yield	0.00%
50-Day Moving Average	$0.3848
Beta	0.92
Avg. Volume	2.25M
PE Ratio	-0.27

52-Week High	$2.75
52-Week Low	$0.162
Market Capitalization	$7.54M
EPS (Annual)	-$2.17
Price to Book	0.55
Revenue Per Employee	$152,007.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

MGRXMangoceuticals Inc

Latest MGRX News